Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00515359 · ClinicalTrials.gov registry record · NA
RCT for Intermittent Versus Continuous Propofol Sedation for Pediatric Brain and Spine MRI Studies
A NA study of Encephalopathy and Developmental Delay and Behavioral Changes, sponsored by Corewell Health West.
- Completed
- Registry status
- NA
- Development phase
- 276
- Enrollment target
- 1
- Study location
NCT00515359: Completed NA study of Encephalopathy and Developmental Delay and Behavioral Changes, sponsored by Corewell Health West.
NCT00515359 is a NA study of Encephalopathy and Developmental Delay and Behavioral Changes that has completed, run by Corewell Health West. The registered enrollment target is 276 participants, above the 175-participant average among 7 other Encephalopathy trials with a reported enrollment target (58% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00515359, a NA study of Encephalopathy and Developmental Delay and Behavioral Changes, has completed, sponsored by Corewell Health West.
- COMPLETED
- Registry status
- NA
- Development phase
- 276 participants
- Enrollment target
- 1
- Study location
Study Summary
RCT for Intermittent versus Continuous Propofol Sedation for Pediatric Brain and Spine MRI Studies
Conditions Studied
Interventions
- PROCEDURE Intermittent Propofol Sedation
- PROCEDURE Continuous Propofol Sedation
Study Locations (1)
Michigan
- Spectrum Health - Grand Rapids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 276 participants |
| Start Date | 2007-06 |
| Est. Completion | 2009-02 |
| Phase | NA |
What the finished NCT00515359 record still lists
NCT00515359 is an interventional study that assigns participants to a tested intervention. The registered 276 participants enrollment target is mid-sized for trials with a published cap, above the 175-participant average among 7 other Encephalopathy trials with a reported enrollment target (58% higher).
The record links to 4 conditions, with Encephalopathy appearing as the primary indexed condition, and to 2 interventions - of which Intermittent Propofol Sedation is the first listed.
NCT00515359 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT00515359 about?
NCT00515359 is a clinical study titled "RCT for Intermittent Versus Continuous Propofol Sedation for Pediatric Brain and Spine MRI Studies". RCT for Intermittent versus Continuous Propofol Sedation for Pediatric Brain and Spine MRI Studies
What is the current status of trial NCT00515359?
This trial is currently completed. It is a NA study. The enrollment target is 276 participants. The study started on 2007-06. Estimated completion is 2009-02.
What conditions does trial NCT00515359 study?
This clinical trial studies the following conditions: Encephalopathy, Developmental Delay and Behavioral Changes, Cord Tumor Compression or Instability, Cord Tethering or Malformation.
What interventions are being tested in trial NCT00515359?
The interventions under investigation include: Intermittent Propofol Sedation (PROCEDURE), Continuous Propofol Sedation (PROCEDURE).
Who is sponsoring clinical trial NCT00515359?
This trial is sponsored by Corewell Health West, which has 38 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00515359 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Encephalopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy
RECRUITING · NA
-
EEG Cap for Identification of Non-Convulsive Status Epilepticus
COMPLETED · NA
-
Novel Arm Restraint For Critically Ill Patients To Reduce Immobility, Sedation, Agitation and Cognitive Impairment
COMPLETED · NA
-
Healthy Little Eyes
RECRUITING
-
CoMind Early Feasibility Study
RECRUITING
-
Automating Delirium Severity in the ICU
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01371630 · 276 participants · Phase 1
Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia
- NCT04192344 · 276 participants · Phase 1
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor
- NCT05294991 · 276 participants · NA
Wellness App for Sleep Disturbance in Hematological Cancer Patients
- NCT05610852 · 276 participants · NA
Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia